Daniel Ohlendorf

Title: The Innovative Contributions of Daniel Ohlendorf

Introduction

Daniel Ohlendorf is a notable inventor based in Berlin, Germany. He has made significant contributions to the field of medicinal chemistry, particularly in the development of compounds aimed at treating Parkinson's disease. His work exemplifies the intersection of innovation and healthcare, showcasing the potential of small molecule compounds in medical applications.

Latest Patents

Ohlendorf holds a patent for "Bicyclic-compounds for use as a medicament, in particular for treatment of Parkinson's disease." This invention relates to novel small molecule compounds characterized by a specific basic structure. The compounds are designed to inhibit the enzyme Catechol-O-methyltransferase (COMT) and exhibit a low off-target profile. They are intended for use as a medicament, particularly in the prevention or treatment of Parkinson's disease. Ohlendorf's patent represents a significant advancement in the search for effective treatments for this debilitating condition. He has 1 patent to his name.

Career Highlights

Throughout his career, Ohlendorf has worked with various organizations, contributing his expertise in medicinal chemistry. His innovative approach to drug development has positioned him as a key figure in the field. His research has the potential to impact the lives of many individuals suffering from Parkinson's disease.

Collaborations

Ohlendorf has collaborated with notable professionals in his field, including Hubert Koester and Lisa Von Kleist. These collaborations have likely enriched his research and contributed to the success of his innovative projects.

Conclusion

Daniel Ohlendorf's work in developing compounds for the treatment of Parkinson's disease highlights the importance of innovation in medicine. His contributions not only advance scientific knowledge but also offer hope for improved therapeutic options for patients.